Latest TB Stories
ANAHEIM, Calif., Oct. 8, 2014 /PRNewswire/ -- Headquartered in Anaheim, California, WholeHealth Products.
Program expands access to care supporting the Diagnostics Access Initiative PLEASANTON, Calif., Sept.
New multi-year grant continues work to study pressing public health crisis TUCSON, Ariz., Sept.
To reduce the burden of tuberculosis and address the issue of drug-resistant TB in the Kyrgyz Republic, Abt Associates has been awarded the U.S.
The vaccine used to protect against tuberculosis disease (bacillus calmette-guerin or BCG) also protects against tuberculosis infection (mycobacterium) as well as protecting against progression from infection to disease.
Robertson Will Lead Initiatives to Accelerate Adoption of New TB Drug Regimens NEW YORK, July 31, 2014 /PRNewswire-USNewswire/ -- TB Alliance, a not-for-profit organization with the
Today, fewer people are dying from HIV/AIDS, tuberculosis, and malaria, according to a new, first-of-its-kind analysis of trend data from 188 countries.
A major new analysis from the Global Burden of Disease Study 2013 published in The Lancet, shows that accelerated progress against the global burden of HIV, malaria, and tuberculosis (TB) has been made since 2000 when governments worldwide adopted Millennium Development Goal (MDG) 6 to combat HIV/AIDS, malaria, and TB.
The mystery of why mycobacteria—a family that includes the microbe that causes TB—are extraordinarily hardy organisms is being unraveled by University of Otago, New Zealand, research that offers new hope for developing a revolutionary class of antibiotics to tackle TB.
- A volcanic mudflow.